Growth Metrics

Insulet (PODD) Profit After Tax (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10.33%
Dec 31, 2025 15.98%
Sep 30, 2025 289.33%
Jun 30, 2025 -36.44%
Mar 31, 2025 -64.85%
Dec 31, 2024 29.94%
Sep 30, 2024 -58.91%
Jun 30, 2024 266.21%
Mar 31, 2024 -50.15%
Dec 31, 2023 99.04%
Sep 30, 2023 90.11%
Jun 30, 2023 14.71%
Mar 31, 2023 40.00%
Dec 31, 2022 426.92%
Sep 30, 2022 85.14%
Jun 30, 2022 -225.90%
Mar 31, 2022 -4.79%
Dec 31, 2021 131.75%
Sep 30, 2021 150.40%
Dec 31, 2020 -247.41%
Sep 30, 2020 -19.44%
Jun 30, 2020 785.71%
Mar 31, 2020 -142.00%
Dec 31, 2019 525.00%
Sep 30, 2019 -42.86%
Jun 30, 2019 -68.18%
Mar 31, 2019 -55.56%
Dec 31, 2018 482.35%
Sep 30, 2018 200.00%
Jun 30, 2018 74.24%
Mar 31, 2018 3.79%
Dec 31, 2017 -208.04%
Sep 30, 2017 71.33%
Jun 30, 2017 22.15%
Mar 31, 2017 -9.00%
Dec 31, 2016 -197.08%
Sep 30, 2016 29.19%
Jun 30, 2016 59.29%
Mar 31, 2016 32.81%
Dec 31, 2015 15.95%
Sep 30, 2015 -9.61%
Jun 30, 2015 -45.91%
Mar 31, 2015 -119.15%
Dec 31, 2014 50.21%
Sep 30, 2014 62.75%
Jun 30, 2014 -373.81%
Mar 31, 2014 -145.76%
Dec 31, 2013 88.26%
Sep 30, 2013 -102.40%
Jun 30, 2013 1.37%
Mar 31, 2013 -4.62%
Dec 31, 2012 17.90%
Sep 30, 2012 14.22%
Jun 30, 2012 2.06%
Mar 31, 2012 -3.09%
Dec 31, 2011 -5.71%
Sep 30, 2011 -67.76%
Jun 30, 2011 17.91%
Mar 31, 2011 52.79%
Dec 31, 2010 -72.38%
Sep 30, 2010 11.75%